Our findings indicate that downregulation of SLC9A2 significantly enhances STAT3 phosphorylation, whereas overexpression of SLC9A2 markedly reduces both STAT3 phosphorylation and nuclear localization in CRC cells. Here, SLC9A2 is linked to colorectal carcinoma.